Phase 2 (Jastreboff 2023) cutaneous category 12.9% at 12 mg vs 1.4% placebo
Participants who pushed through this window rarely discontinued due to side effects later in the trial
GLP-1 receptor agonists such as semaglutide can help manage blood glucose, body weight, and certain cardiometabolic risks when prescribed for an appropriate patient
External resources Tirzepatide-induced gastrointestinal manifestations: a systematic review and meta-analysis (PMC) Effects of GLP-1 receptor agonist on changes in the gut bacterium (Scientific Reports) For researchers serious about optimizing their GLP-1 protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, proven protocols, and a community of thousands who have navigated these exact questions
Additionally, rapid weight loss associated with these medications might sometimes precipitate headaches through various metabolic changes, though this mechanism requires further study
Here's what I carry daily: Naturally soothing for the stomach
